Conjunctivoplasty reshapes or removes excess conjunctival tissue from the surface of the eye, and most people notice meaningful improvement in comfort and appearance within a few weeks of the procedure. The surgery itself is typically brief, performed under local anesthesia, and the recovery period involves a predictable sequence of redness, mild discomfort, and gradual clearing. But the “before and after” experience depends heavily on why the surgery is being done in the first place, what technique the surgeon uses, and how diligently you follow postoperative care. The gap between the irritated, watery eye that sends someone to the operating room and the smooth, quiet surface they get back is usually dramatic, though the path between those two points has details worth understanding.
Why the Surgery Is Done
Conjunctivoplasty is not a single operation for a single condition. The term covers any surgical reconstruction or reshaping of the conjunctiva, the thin transparent membrane that lines the white of the eye and the inside of the eyelids. The two most common reasons a surgeon recommends it are conjunctivochalasis and pterygium, and your “before” experience will look quite different depending on which one you have.
Conjunctivochalasis is a condition where the conjunctiva becomes loose and redundant, forming folds that pool along the lower eyelid margin. Those folds interfere with normal tear drainage, trap debris, and create chronic irritation that mimics dry eye. The cause is not fully understood but likely involves aging of the conjunctival tissue, chronic inflammation, mechanical friction from blinking, and disrupted tear film stability.1Survey of Ophthalmology. Conjunctivochalasis: a systematic review People with conjunctivochalasis often describe a persistent foreign-body sensation, excessive tearing that paradoxically coexists with dryness, and blurred vision that clears temporarily after blinking.
Pterygium is a wedge-shaped growth of fibrovascular tissue that creeps from the conjunctiva onto the cornea. It is strongly linked to ultraviolet light exposure and tends to recur even after removal. When a surgeon excises a pterygium, the bare area left behind needs coverage, and that coverage is a form of conjunctivoplasty, whether it involves grafting conjunctival tissue from another part of the eye or laying down an amniotic membrane.
Less commonly, conjunctivoplasty is performed to repair scarring from autoimmune conditions like ocular cicatricial pemphigoid, chemical burns, or prior surgeries that left the conjunctival surface irregular. In one case report, amniotic membrane transplantation restored fornix depth, reduced inflammation, and allowed goblet cells to repopulate the reconstructed surface.2PubMed. Amniotic membrane transplantation elicits goblet cell repopulation after conjunctival reconstruction in a case of severe ocular cicatricial pemphigoid
What You Try Before Surgery
For conjunctivochalasis in particular, surgery is not the first step. Most eye care providers will run through a series of conservative treatments before referring you to a surgeon. The standard approach targets the dry eye and inflammatory component of the condition: preservative-free artificial tears, anti-inflammatory drops, omega-3 supplements, and short courses of topical steroids.3Journal of Medical Optometry. Conjunctivochalasis: A Report of Two Cases A steroid pulse is often tried before surgical referral because an ophthalmologist would likely prescribe one anyway before operating.
When conservative treatment is compared head-to-head with a minor office procedure like electrocoagulation, the gap in outcomes is telling. In one study, patients treated with anti-inflammatory and lubricant drops for four weeks saw improvement only in their symptom scores, while objective measurements of tear stability and conjunctival irregularity did not budge. The electrocoagulation group, by contrast, showed significant improvement in both symptoms and clinical signs.4PubMed Central. Comparison of Electrocoagulation and Conventional Medical Drops for Treatment of Conjunctivochalasis: Short-Term Results That result helps explain why many patients with moderate-to-severe conjunctivochalasis end up in surgery: the drops manage symptoms but do not fix the underlying structural problem.
For pterygium, the threshold for surgery is usually more straightforward. If the growth is advancing toward the visual axis, distorting the corneal surface enough to cause astigmatism, or simply large enough to be cosmetically bothersome, the surgeon will recommend excision and reconstruction. Drops and sunglasses can slow growth but cannot reverse it.
Surgical Techniques and What They Mean for Recovery
The technique your surgeon uses will shape both the duration of the operation and the character of your recovery. For conjunctivochalasis, the two main approaches are cauterization of the redundant folds and excision of the excess tissue, sometimes with an amniotic membrane graft placed over the exposed area.1Survey of Ophthalmology. Conjunctivochalasis: a systematic review Newer variations use high-frequency electrocautery with specialized forceps, eliminating sutures entirely and shortening the procedure.5PubMed Central. Efficacy of a novel surgical approach: sutureless correction of conjunctivochalasis using new conjunctival forceps combined with high-frequency electrocautery
For pterygium, the choice is usually between a conjunctival autograft (tissue harvested from the same eye, typically the upper portion hidden under the lid) and an amniotic membrane graft (processed donor tissue). A large review spanning 30 years of studies found average recurrence rates around 8% for conjunctival autografts and 9% for amniotic membrane grafts, with limbal conjunctival autografts performing slightly better at about 6%.6PubMed Central. Conjunctival and Limbal Conjunctival Autograft vs. Amniotic Membrane Graft in Primary Pterygium Surgery: A 30-Year Comprehensive Review Techniques that combined autografts with amniotic membrane yielded the lowest recurrence of all, under 2%.
The graft also needs to be secured in place, and here you have two options with real practical differences. Fibrin glue shaves roughly 17 minutes off the operation compared to sutures and may lead to about half the recurrence rate. But it comes with a slightly higher chance of graft-related complications like the graft pulling away from the surface or retracting during healing.7PubMed Central. Fibrin glue versus sutures for conjunctival autografting in primary pterygium surgery Sutures are the traditional approach, generally more secure, but they add time to the procedure and can cause their own irritation during recovery. Most surgeons now favor fibrin glue for routine cases and reserve sutures for eyes where graft stability is a concern.
The First Week After Surgery
Regardless of the specific technique, the first few days follow a broadly similar pattern. You will leave the clinic with an eye patch or shield and instructions to start medicated drops within hours or by the next morning. The operated eye will be visibly red, and many people describe a gritty, stinging sensation that peaks around 24 to 48 hours after the procedure. This is normal surface irritation, not a sign of complications.
A typical postoperative regimen involves an antibiotic-steroid combination drop used four times daily for the first week, along with preservative-free lubricating drops used at the same frequency for about a month. After the first week, the steroid is often switched to a milder formulation that continues for several additional weeks to keep inflammation in check without the side-effect profile of stronger steroids.5PubMed Central. Efficacy of a novel surgical approach: sutureless correction of conjunctivochalasis using new conjunctival forceps combined with high-frequency electrocautery If sutures were placed, they may dissolve on their own over two to three weeks or be removed at a follow-up visit.
During this first week, most people notice the redness is intense but shrinking day by day. Any amniotic membrane placed on the surface gradually dissolves on its own. If fibrin glue was used, the graft edges may look slightly raised or uneven initially, then flatten and integrate over the following days. Vision in the operated eye is typically blurry from the drops and residual swelling but begins clearing by the end of the first week.
Weeks Two Through Six
The middle phase of recovery is where many patients feel a mismatch between what they see and what they feel. The eye may still look pink or mildly inflamed, but the foreign-body sensation that dominated the first week has usually faded considerably. You will still be using your lubricating drops regularly, and the milder steroid drop continues to taper off over this period.
By around the four-to-six-week mark, most eyes have returned to a nearly normal appearance. The conjunctiva has healed over the surgical site, and the graft, if one was placed, has smoothed out. People who had conjunctivochalasis typically notice that the tearing and pooling sensation they had been living with for months or years is gone. The lower lid margin looks clean and flat instead of bunched up.
For pterygium patients, this is the phase where the cosmetic improvement becomes apparent. The fleshy, vascularized wedge that once covered part of the cornea has been replaced by a smooth, white-appearing surface. Some residual redness at the graft margins is common and continues to fade over the following months. Any astigmatism caused by the pterygium pressing on the cornea may partially or fully resolve as the corneal surface regularizes, though this can take several months to stabilize.
Long-Term Results
The question patients care about most is whether the problem stays fixed. The evidence here is reassuring but comes with caveats. A ten-year review of pterygium surgeries found an overall recurrence rate of just 1% when conjunctival autografts were used, compared to 8% for deeper amniotic membrane grafts and a much higher 25% for simple excision with mitomycin-C alone.8PubMed Central. Clinical outcomes of pterygium surgery over a ten-year period: a review of recurrence and complication rates An even longer-term study with an average follow-up of 16 years found zero recurrences in patients who received conjunctival grafts, and no late complications.9Contact Lens and Anterior Eye. Very long term success of pterygium surgery with conjunctival graft
These numbers are encouraging, but they come from populations with varying levels of UV exposure and follow-up completeness. A study from a high-UV-exposure country with a minimum 11-year follow-up found one recurrence out of 15 patients and high satisfaction scores averaging about 9.7 out of 10. Interestingly, seven of those 15 patients reported more than three hours of daily sunlight exposure and most did not regularly wear protective sunglasses, yet the graft still held.10PubMed Central. Long-Term Surgical Outcome of Pterygium Excision and Conjunctival Limbal Autograft: Minimum 11 years Follow-up Study in a Country with High Ultraviolet Exposure That finding speaks to the durability of a well-placed autograft, though wearing UV-blocking sunglasses after surgery is still standard advice.
For conjunctivochalasis, long-term data is harder to come by because the condition has received less research attention than pterygium. Recurrence can happen, particularly if the underlying inflammatory cycle is not managed. Continued use of preservative-free lubricants and periodic follow-ups with your eye care provider help catch early signs of redundant tissue returning.
Risks and Complications Worth Knowing About
Serious complications from conjunctivoplasty are uncommon, but they exist and are worth understanding before you go in. The most frequently reported issues after pterygium surgery with grafting include graft dehiscence (the graft separating from the underlying tissue), graft retraction, and granuloma formation, which is a small inflammatory nodule at the surgical site.7PubMed Central. Fibrin glue versus sutures for conjunctival autografting in primary pterygium surgery These tend to occur within the first few weeks and are usually manageable with additional drops, a minor office procedure, or occasionally a revision.
Infection is a risk with any eye surgery, though it is rare when antibiotic drops are used as directed. A more subtle risk is that the graft site on the upper conjunctiva (where tissue was harvested) can scar or develop adhesions, which occasionally causes discomfort with upward gaze. Surgeons minimize this by taking thin grafts and leaving enough healthy tissue behind to heal cleanly.
For conjunctivochalasis procedures that use cauterization, the main risk is under- or over-treatment. Too little cautery and the redundant folds persist. Too much and the conjunctiva can tighten excessively, causing a pulling sensation or restricting eye movement. This is rare with experienced surgeons but worth discussing at your preoperative consultation.
Any procedure involving mitomycin-C, an anti-metabolite sometimes applied to reduce recurrence risk, carries its own concerns. While low concentrations used briefly during surgery are generally safe, this agent suppresses tissue regrowth and can thin the sclera if overused. The ten-year review mentioned earlier found that primary excision with mitomycin-C and no graft had the highest recurrence rate of the techniques studied, suggesting that the drug alone is not a reliable substitute for proper tissue coverage.8PubMed Central. Clinical outcomes of pterygium surgery over a ten-year period: a review of recurrence and complication rates
Realistic Expectations for Appearance
If you are having conjunctivoplasty for a medical condition like pterygium or conjunctivochalasis, the cosmetic improvement is a welcome side effect rather than the primary goal. The operated area will look significantly better than it did before surgery, but it will not look like a completely untouched eye. A faint area of slightly different texture or very mild pinkness at the former graft site is common and usually visible only on close inspection. Most patients and their friends cannot distinguish the operated eye from the non-operated one at conversational distance within a few months.
Satisfaction data supports this. In the long-term follow-up study from a high-UV country, 11 of 15 patients reported being completely satisfied, and the lowest score anyone gave was 7 out of 10.10PubMed Central. Long-Term Surgical Outcome of Pterygium Excision and Conjunctival Limbal Autograft: Minimum 11 years Follow-up Study in a Country with High Ultraviolet Exposure The patients who scored lower tended to have some residual redness or mild asymmetry rather than functional problems.
One factor that catches people off guard is the timeline. The eye looks worst at day two or three, when bruising and swelling peak. It looks presentable by two weeks, good by six weeks, and best by three to six months. Patients who judge their result at the one-week mark are almost always judging too early.
Cosmetic Eye Whitening Is a Different Procedure Entirely
Some people searching for conjunctivoplasty results are actually looking at cosmetic “eye whitening” procedures, which involve removing the conjunctiva to eliminate redness or yellowish discoloration. These procedures are marketed under names like I-BRITE and are performed in some clinics for purely cosmetic reasons. They deserve a clear warning.
A case series from a major eye center reported outcomes in 17 eyes that underwent cosmetic conjunctival removal. Sixteen of the 17 developed persistent epithelial defects on the eye surface, with 10 requiring amniotic membrane grafting to help the surface heal. Four eyes in two patients developed compromise of the limbal stem cells, the critical population of cells that maintain the corneal surface. One patient developed infectious scleritis and double vision from scarring. Another developed scleral necrosis, infectious scleritis, and infectious endophthalmitis, ultimately requiring three-drug immunosuppressive therapy for ongoing non-infectious scleritis.11PubMed. Complications related to a cosmetic eye-whitening procedure
Separately, necrotizing scleritis has been reported as a direct complication of cosmetic eye whitening procedures that use mitomycin-C during and after surgery.12PubMed Central. Necrotizing scleritis as a complication of cosmetic eye whitening procedure Necrotizing scleritis is one of the most painful and destructive inflammatory conditions the eye can develop, and treating it is far more difficult than treating the original redness.
The difference between a medically indicated conjunctivoplasty and a cosmetic eye whitening procedure is not just a matter of degree. A surgeon removing a pterygium or tightening redundant conjunctiva is restoring normal anatomy. A cosmetic whitening procedure strips away healthy tissue to achieve a whiter appearance, and in doing so can remove the very structures the eye depends on to maintain its surface. If you are considering any procedure on the conjunctiva for purely cosmetic reasons, the complication profile is substantially worse than what you would face with a medically necessary surgery, and you should weigh that carefully.
When Recurrence Happens and What It Looks Like
Recurrence after pterygium surgery tends to show up within the first year, most often between one and five months postoperatively. One study found a mean time to recurrence of about two to three months regardless of whether a conjunctival autograft or amniotic membrane graft was used.13Eye. Comparison of de-epithelialized amniotic membrane transplantation and conjunctival autograft after primary pterygium excision You will recognize it as a return of the fleshy, pinkish tissue creeping from the inner corner of the eye toward the pupil. It does not happen suddenly; it is a gradual regrowth that your surgeon will spot at follow-up visits before you notice it yourself in the mirror.
Recurrence rates vary enormously by technique, as covered earlier. The 30-year review found that using fibrin glue instead of sutures cut recurrence roughly in half across all graft types.6PubMed Central. Conjunctival and Limbal Conjunctival Autograft vs. Amniotic Membrane Graft in Primary Pterygium Surgery: A 30-Year Comprehensive Review If recurrence does happen, the second surgery generally uses a more aggressive grafting strategy and has a good track record of preventing further regrowth.
For conjunctivochalasis, “recurrence” looks like the return of redundant folds along the lower lid margin and a resurgence of tearing, foreign-body sensation, or blurry vision. Maintaining an anti-inflammatory eye drop regimen and using preservative-free lubricants long-term can delay or prevent this. Some patients find that a single cauterization procedure gives them years of relief, while others with more severe baseline disease need a more definitive excision.
What to Ask Your Surgeon Before the Procedure
Not all conjunctivoplasty consultations cover the same ground, and a few questions can clarify your personal “before and after” expectations. Ask which technique the surgeon plans to use and why. If you are having pterygium surgery, ask specifically whether a conjunctival autograft will be used and how the graft will be secured. Given the evidence favoring autografts over bare excision, a surgeon who does not plan to place a graft should be able to explain why.
Ask about the postoperative drop schedule. Some regimens involve multiple medications at overlapping intervals, and knowing the plan in advance helps you stay organized during the period when your eye is uncomfortable and you are least inclined to fiddle with bottles. Ask how long the surgeon expects visible redness to last. This varies by technique and individual healing, but most experienced surgeons can give you a ballpark based on what they see in their own patients. And ask when you can resume wearing contact lenses if applicable, since most surgeons want the surface fully healed before any lens touches it, which typically means at least four to six weeks.
Finally, ask about activity restrictions. Most patients can return to desk work within a few days, but swimming, dusty environments, and heavy exercise are typically off-limits for two to four weeks. The specific timeline depends on your surgery and your surgeon’s preferences, so getting clear guidance up front prevents unnecessary worry during recovery.